Travere Therapeutics, Sony And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Amrize (NYSE:AMRZ), Baidu (NASDAQ:BIDU)

Group 1 - U.S. stock futures are lower, with Dow futures down approximately 0.2% [1] - Travere Therapeutics Inc expects total U.S. net product sales of $127 million for Q4 and $410 million for 2025 [1] - Travere Therapeutics will restart its Phase 3 HARMONY study in Q1 2026 [1] Group 2 - Travere Therapeutics shares fell 28.2% to $24.50 in pre-market trading [2] - Lulu's Fashion Lounge Holdings Inc shares decreased 10.4% to $10.89 after a significant rise of 79% on Monday [3] - Other stocks such as Graf Global Corp, Ready Capital Corp, and Baidu Inc also experienced declines in pre-market trading [3]